Trials / Not Yet Recruiting
Not Yet RecruitingNCT05416554
Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford
Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford - A Pilot Study
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to assess the feasibility of performing neuropsychological testing to measure the cognitive performance of individuals following Axicabtagene ciloleucel CAR-T therapy at Stanford.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Neuropsychological testing | Upon completion of the consent, the subject will be booked into an available 90 minute in-person or remote neuropsychological testing |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2026-12-01
- Completion
- 2027-12-01
- First posted
- 2022-06-13
- Last updated
- 2025-02-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05416554. Inclusion in this directory is not an endorsement.